Merck has signed a licensing deal with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion for its experimental heart ...

Rahway: Merck, known as MSD outside of the United States and Canada, and Jiangsu Hengrui Pharmaceuticals Co., Ltd., a global ...

Under the agreement, Hengrui Pharma has granted Merck exclusive rights to develop, manufacture and commercialize HRS-5346 worldwide, excluding Greater China region.

A licensing deal with Jiangsu Hengrui Pharmaceuticals puts Merck in a competitive race to develop a medicine that targets a ...

With the ongoing global climate change and energy structure transformation, green energy efficiency has become one of the key indicators for achieving sustainable development. This study uses panel ...

Previously, SMM made the following reminder about the discontinuation of high-grade NPI price updates by region: SMM Announcement: The Publication of High-Grade NPI Prices by Region Will Soon Be ...

Lead Prices Reverse and Pull Back, Spot Market Transactions Show Significant Divergence】 SMM March 28: In the Shanghai market, Chihong lead was quoted at 17,425-17,475 yuan/mt, with a premium of 0-50 ...

The recent 6th Second Member Representative Conference of the Jiangsu Bowling Sports Association marked a significant milestone in the region's bowling community. This well-attended event served as a ...